Chugai OTC Stock Financials

CHGCF -  USA Stock  

USD 34.49  0.58  1.65%

Understanding current and past Chugai Pharmaceutical Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of Chugai Pharmaceutical's financial statements are interrelated, with each one affecting the others. For example, an increase in Chugai Pharmaceutical's assets may result in an increase in income on the income statement. Because of this, it is necessary to analyze all of Chugai Pharmaceutical's financials over time to get the whole picture.
.
Use fundamental data analysis to double-check all available reported financial drivers of Chugai Pharmaceutical to find out if markets are presently mispricing the company. We were able to break down thirty-three available fundamental indicators for Chugai Pharmaceutical, which can be compared to its rivals. To make sure the equity is not overpriced, please confirm all Chugai Pharmaceutical financials, including its cash per share, number of employees, and the relationship between the ebitda and book value per share . Given that Chugai Pharmaceutical has a price to earning of 29.90 X, we suggest you to validate Chugai Pharmaceutical prevailing market performance to make sure the company can sustain itself down the road. Use Chugai Pharmaceutical to protect your portfolios against small market fluctuations. The stock experiences a bearish sentiment with high volatility. Check odds of Chugai Pharmaceutical to be traded at $33.46 in 90 days.

Chugai Fundamentals 

 
Refresh
With this module, you can analyze Chugai financials for your investing period. You should be able to track the changes in Chugai Pharmaceutical individual financial statements over time to develop the understanding of its risk, liquidity, profitability, or other critical and vital indicators.
  Chance Of Financial Distress
Less than 46
Chugai Pharmaceutical has less than 46 (%) percent chance of experiencing financial distress in the next two years of operations. The calculation of odds of distress for Chugai Pharmaceutical otc stock is tightly coupled with the Probability of Bankruptcy. It complements the equity performance score by supplying investors with insight into company financials without requiring them to know too much about all of the complex accounting and financial indicators surrounding the entity. More Info
The data published in Chugai Pharmaceutical's official financial statements usually reflect Chugai Pharmaceutical's business processes, product offerings, services, and other fundamental events. But there are other numbers, ratios, or fundamental indicators derived from these statements that are easier to understand and visualize within the underlying realities that drive quantitative information of Chugai Pharmaceutical. For example, before you start analyzing numbers published by Chugai accountants, it's critical to develop an understanding of what Chugai Pharmaceutical's liquidity, profitability, and earnings quality are in the context of the Healthcare space in which it operates.
Please note, the presentation of Chugai Pharmaceutical's financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Chugai Pharmaceutical's management is honest, while the outside auditors are strict and uncompromising. Whatever the case, the imprecision that can be found in Chugai Pharmaceutical's accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Chugai Pharmaceutical. Please utilize our Beneish M Score to check the likelihood of Chugai Pharmaceutical's management to manipulate its earnings.

Chugai Pharmaceutical Company Summary

Chugai Pharmaceutical competes with Johnson Johnson, ROCHE HOLDINGS, Pfizer, Eli Lilly, and Merck. Chugai Pharmaceutical Co., Ltd., together with its subsidiaries, engages in the research, development, manufacturing, sale, importation, and exportation of pharmaceuticals in Japan and internationally. Chugai Pharmaceutical Co., Ltd. is a subsidiary of Roche Holding Ltd. Chugai Pharmaceutical operates under Drug ManufacturersGeneral classification in the United States and is traded on OTC Exchange. It employs 7555 people.
InstrumentUSA OTC Stock View All
ExchangeOTC Exchange
Business AddressNihonbashi Mitsui Tower
SectorHealthcare
IndustryDrug Manufacturers—General
BenchmarkDOW
Websitewww.chugai-pharm.co.jp
Phone81 3 3281 6611
CurrencyUSD - US Dollar

Chugai Pharmaceutical Key Financial Ratios

Generally speaking, Chugai Pharmaceutical's financial ratios allow both analysts and investors to convert raw data from Chugai Pharmaceutical's financial statements into concise, actionable information that can be used to evaluate the performance of Chugai Pharmaceutical over time and compare it to other companies across industries. There are many critical financial ratios that investors are exposed to on a daily basis, but they are usually grouped into few meaningful categories from each financial statement that Chugai Pharmaceutical reports annually and quarterly.

Chugai Financial Ratios Relationships

Comparative valuation techniques use various fundamental indicators to help in determining Chugai Pharmaceutical's current stock value. Our valuation model uses many indicators to compare Chugai Pharmaceutical value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Chugai Pharmaceutical competition to find correlations between indicators driving Chugai Pharmaceutical's intrinsic value. More Info.
Chugai Pharmaceutical is rated third in price to earning category among related companies. It is rated fifth in return on equity category among related companies reporting about  0.79  of Return On Equity per Price to Earning. The ratio of Price to Earning to Return On Equity for Chugai Pharmaceutical is roughly  1.27 

Chugai Pharmaceutical Systematic Risk

Chugai Pharmaceutical's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. Chugai Pharmaceutical volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The output start index for this execution was twenty with a total number of output elements of fourty-one. The Beta measures systematic risk based on how returns on Chugai Pharmaceutical correlated with the market. If Beta is less than 0 Chugai Pharmaceutical generally moves in the opposite direction as compared to the market. If Chugai Pharmaceutical Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Chugai Pharmaceutical is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Chugai Pharmaceutical is generally in the same direction as the market. If Beta > 1 Chugai Pharmaceutical moves generally in the same direction as, but more than the movement of the benchmark. View also all equity analysis or get more info about beta statistic functions indicator.

About Chugai Pharmaceutical Financials

What exactly are Chugai Pharmaceutical Financials? Typically, a company's financial statements are the reports that show the financial position of the company. Three primary documents fall into the category of financial statements. These documents include Chugai Pharmaceutical's income statement, its balance sheet, and the statement of cash flows. Potential Chugai Pharmaceutical investors and stakeholders use financial statements to determine how well the company is positioned to perform in the future. Although Chugai Pharmaceutical investors may use each financial statement separately, they are all related. The changes in Chugai Pharmaceutical's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Chugai Pharmaceutical's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. Please read more on our technical analysis and fundamental analysis pages.

Chugai Pharmaceutical October 23, 2021 Opportunity Range

Along with financial statement analysis, the daily predictive indicators of Chugai Pharmaceutical help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Chugai Pharmaceutical. We use our internally-developed statistical techniques to arrive at the intrinsic value of Chugai Pharmaceutical based on widely used predictive technical indicators. In general, we focus on analyzing Chugai OTC Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Chugai Pharmaceutical's daily price indicators and compare them against related drivers.
Information Ratio(0.16)
Maximum Drawdown11.08
Continue to Trending Equities. Note that the Chugai Pharmaceutical information on this page should be used as a complementary analysis to other Chugai Pharmaceutical's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Idea Analyzer module to analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas.

Complementary Tools for Chugai OTC Stock analysis

When running Chugai Pharmaceutical price analysis, check to measure Chugai Pharmaceutical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Chugai Pharmaceutical is operating at the current time. Most of Chugai Pharmaceutical's value examination focuses on studying past and present price action to predict the probability of Chugai Pharmaceutical's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Chugai Pharmaceutical's price. Additionally, you may evaluate how the addition of Chugai Pharmaceutical to your portfolios can decrease your overall portfolio volatility.
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
Go
Piotroski F Score
Get Piotroski F Score based on binary analysis strategy of nine different fundamentals
Go
Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance
Go
Global Correlations
Find global opportunities by holding instruments from different markets
Go
My Watchlist Analysis
Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like
Go
Fund Screener
Find activelly-traded funds from around the world traded on over 30 global exchanges
Go
Equity Search
Search for activelly traded equities including funds and ETFs from over 30 global markets
Go
Portfolio Holdings
Check your current holdings and cash postion to detemine if your portfolio needs rebalancing
Go
Portfolio Center
All portfolio management and optimization tools to improve performance of your portfolios
Go
The market value of Chugai Pharmaceutical is measured differently than its book value, which is the value of Chugai that is recorded on the company's balance sheet. Investors also form their own opinion of Chugai Pharmaceutical's value that differs from its market value or its book value, called intrinsic value, which is Chugai Pharmaceutical's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Chugai Pharmaceutical's market value can be influenced by many factors that don't directly affect Chugai Pharmaceutical underlying business (such as pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Chugai Pharmaceutical's value and its price as these two are different measures arrived at by different means. Investors typically determine Chugai Pharmaceutical value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Chugai Pharmaceutical's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.